Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia
Identifieur interne : 000F65 ( Pmc/Corpus ); précédent : 000F64; suivant : 000F66Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia
Auteurs : Groesbeck P. Parham ; Vikrant V. Sahasrabuddhe ; Mulindi H. Mwanahamuntu ; Bryan E. Shepherd ; Michael L. Hicks ; Elizabeth M. Stringer ; Sten H. VermundSource :
- Gynecologic oncology [ 0090-8258 ] ; 2006.
Abstract
HIV-infected women living in resource-constrained nations like Zambia are now accessing antiretroviral therapy and thus may live long enough for HPV-induced cervical cancer to manifest and progress. We evaluated the prevalence and predictors of cervical squamous intraepithelial lesions (SIL) among HIV-infected women in Zambia.
We screened 150 consecutive, non-pregnant HIV-infected women accessing HIV/AIDS care services in Lusaka, Zambia. We collected cervical specimens for cytological analysis by liquid-based monolayer cytology (ThinPrep Pap Test®) and HPV typing using the Roche Linear Array® PCR assay.
The median age of study participants was 36 years (range 23-49 years) and their median CD4+ count was 165/μL (range 7-942). The prevalence of SIL on cytology was 76% (114/150), of which 23.3% (35/150) women had low-grade SIL, 32.6% (49/150) had high-grade SIL, and 20% (30/150) had lesions suspicious for squamous cell carcinoma (SCC). High-risk HPV types were present in 85.3% (128/150) women. On univariate analyses, age of the participant, CD4+ cell count, and presence of any high-risk HPV type were significantly associated with the presence of severely abnormal cytological lesions (i.e., high-grade SIL and lesions suspicious for SCC). Multivariable logistic regression modeling suggested the presence of any high-risk HPV type as an independent predictor of severely abnormal cytology (adjusted OR: 12.4, 95% CI 2.62-58.1,
The high prevalence of abnormal squamous cytology in our study is one of the highest reported in any population worldwide. Screening of HIV-infected women in resource-constrained settings like Zambia should be implemented to prevent development of HPV-induced SCC.
Url:
DOI: 10.1016/j.ygyno.2006.06.015
PubMed: 16875716
PubMed Central: 2748907
Links to Exploration step
PMC:2748907Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia</title>
<author><name sortKey="Parham, Groesbeck P" sort="Parham, Groesbeck P" uniqKey="Parham G" first="Groesbeck P." last="Parham">Groesbeck P. Parham</name>
<affiliation><nlm:aff id="A1">School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="A2">Center for Infectious Disease Research in Zambia, Lusaka, Zambia, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Sahasrabuddhe, Vikrant V" sort="Sahasrabuddhe, Vikrant V" uniqKey="Sahasrabuddhe V" first="Vikrant V." last="Sahasrabuddhe">Vikrant V. Sahasrabuddhe</name>
<affiliation><nlm:aff id="A3">School of Medicine, Vanderbilt University, Nashville, TN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mwanahamuntu, Mulindi H" sort="Mwanahamuntu, Mulindi H" uniqKey="Mwanahamuntu M" first="Mulindi H." last="Mwanahamuntu">Mulindi H. Mwanahamuntu</name>
<affiliation><nlm:aff id="A4">University Teaching Hospital, Lusaka, Zambia, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Shepherd, Bryan E" sort="Shepherd, Bryan E" uniqKey="Shepherd B" first="Bryan E." last="Shepherd">Bryan E. Shepherd</name>
<affiliation><nlm:aff id="A3">School of Medicine, Vanderbilt University, Nashville, TN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Hicks, Michael L" sort="Hicks, Michael L" uniqKey="Hicks M" first="Michael L." last="Hicks">Michael L. Hicks</name>
<affiliation><nlm:aff id="A5">Pontiac Cancer Institute, Pontiac, Michigan, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Stringer, Elizabeth M" sort="Stringer, Elizabeth M" uniqKey="Stringer E" first="Elizabeth M." last="Stringer">Elizabeth M. Stringer</name>
<affiliation><nlm:aff id="A1">School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="A2">Center for Infectious Disease Research in Zambia, Lusaka, Zambia, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Vermund, Sten H" sort="Vermund, Sten H" uniqKey="Vermund S" first="Sten H." last="Vermund">Sten H. Vermund</name>
<affiliation><nlm:aff id="A2">Center for Infectious Disease Research in Zambia, Lusaka, Zambia, USA</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="A3">School of Medicine, Vanderbilt University, Nashville, TN, USA</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">16875716</idno>
<idno type="pmc">2748907</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2748907</idno>
<idno type="RBID">PMC:2748907</idno>
<idno type="doi">10.1016/j.ygyno.2006.06.015</idno>
<date when="2006">2006</date>
<idno type="wicri:Area/Pmc/Corpus">000F65</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000F65</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia</title>
<author><name sortKey="Parham, Groesbeck P" sort="Parham, Groesbeck P" uniqKey="Parham G" first="Groesbeck P." last="Parham">Groesbeck P. Parham</name>
<affiliation><nlm:aff id="A1">School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="A2">Center for Infectious Disease Research in Zambia, Lusaka, Zambia, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Sahasrabuddhe, Vikrant V" sort="Sahasrabuddhe, Vikrant V" uniqKey="Sahasrabuddhe V" first="Vikrant V." last="Sahasrabuddhe">Vikrant V. Sahasrabuddhe</name>
<affiliation><nlm:aff id="A3">School of Medicine, Vanderbilt University, Nashville, TN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mwanahamuntu, Mulindi H" sort="Mwanahamuntu, Mulindi H" uniqKey="Mwanahamuntu M" first="Mulindi H." last="Mwanahamuntu">Mulindi H. Mwanahamuntu</name>
<affiliation><nlm:aff id="A4">University Teaching Hospital, Lusaka, Zambia, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Shepherd, Bryan E" sort="Shepherd, Bryan E" uniqKey="Shepherd B" first="Bryan E." last="Shepherd">Bryan E. Shepherd</name>
<affiliation><nlm:aff id="A3">School of Medicine, Vanderbilt University, Nashville, TN, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Hicks, Michael L" sort="Hicks, Michael L" uniqKey="Hicks M" first="Michael L." last="Hicks">Michael L. Hicks</name>
<affiliation><nlm:aff id="A5">Pontiac Cancer Institute, Pontiac, Michigan, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Stringer, Elizabeth M" sort="Stringer, Elizabeth M" uniqKey="Stringer E" first="Elizabeth M." last="Stringer">Elizabeth M. Stringer</name>
<affiliation><nlm:aff id="A1">School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="A2">Center for Infectious Disease Research in Zambia, Lusaka, Zambia, USA</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Vermund, Sten H" sort="Vermund, Sten H" uniqKey="Vermund S" first="Sten H." last="Vermund">Sten H. Vermund</name>
<affiliation><nlm:aff id="A2">Center for Infectious Disease Research in Zambia, Lusaka, Zambia, USA</nlm:aff>
</affiliation>
<affiliation><nlm:aff id="A3">School of Medicine, Vanderbilt University, Nashville, TN, USA</nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Gynecologic oncology</title>
<idno type="ISSN">0090-8258</idno>
<idno type="eISSN">1095-6859</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Objectives</title>
<p id="P2">HIV-infected women living in resource-constrained nations like Zambia are now accessing antiretroviral therapy and thus may live long enough for HPV-induced cervical cancer to manifest and progress. We evaluated the prevalence and predictors of cervical squamous intraepithelial lesions (SIL) among HIV-infected women in Zambia.</p>
</sec>
<sec sec-type="methods" id="S2"><title>Methods</title>
<p id="P3">We screened 150 consecutive, non-pregnant HIV-infected women accessing HIV/AIDS care services in Lusaka, Zambia. We collected cervical specimens for cytological analysis by liquid-based monolayer cytology (ThinPrep Pap Test®) and HPV typing using the Roche Linear Array® PCR assay.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P4">The median age of study participants was 36 years (range 23-49 years) and their median CD4+ count was 165/μL (range 7-942). The prevalence of SIL on cytology was 76% (114/150), of which 23.3% (35/150) women had low-grade SIL, 32.6% (49/150) had high-grade SIL, and 20% (30/150) had lesions suspicious for squamous cell carcinoma (SCC). High-risk HPV types were present in 85.3% (128/150) women. On univariate analyses, age of the participant, CD4+ cell count, and presence of any high-risk HPV type were significantly associated with the presence of severely abnormal cytological lesions (i.e., high-grade SIL and lesions suspicious for SCC). Multivariable logistic regression modeling suggested the presence of any high-risk HPV type as an independent predictor of severely abnormal cytology (adjusted OR: 12.4, 95% CI 2.62-58.1, <italic>p</italic>
=0.02).</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P5">The high prevalence of abnormal squamous cytology in our study is one of the highest reported in any population worldwide. Screening of HIV-infected women in resource-constrained settings like Zambia should be implemented to prevent development of HPV-induced SCC.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article" xml:lang="EN"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">0365304</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3932</journal-id>
<journal-id journal-id-type="nlm-ta">Gynecol Oncol</journal-id>
<journal-title>Gynecologic oncology</journal-title>
<issn pub-type="ppub">0090-8258</issn>
<issn pub-type="epub">1095-6859</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">16875716</article-id>
<article-id pub-id-type="pmc">2748907</article-id>
<article-id pub-id-type="doi">10.1016/j.ygyno.2006.06.015</article-id>
<article-id pub-id-type="manuscript">NIHMS132957</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Parham</surname>
<given-names>Groesbeck P.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Sahasrabuddhe</surname>
<given-names>Vikrant V.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Mwanahamuntu</surname>
<given-names>Mulindi H.</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Shepherd</surname>
<given-names>Bryan E.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Hicks</surname>
<given-names>Michael L.</given-names>
</name>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Stringer</surname>
<given-names>Elizabeth M.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Vermund</surname>
<given-names>Sten H.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>
School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA</aff>
<aff id="A2"><label>b</label>
Center for Infectious Disease Research in Zambia, Lusaka, Zambia, USA</aff>
<aff id="A3"><label>c</label>
School of Medicine, Vanderbilt University, Nashville, TN, USA</aff>
<aff id="A4"><label>d</label>
University Teaching Hospital, Lusaka, Zambia, USA</aff>
<aff id="A5"><label>e</label>
Pontiac Cancer Institute, Pontiac, Michigan, USA</aff>
<author-notes><fn fn-type="corresp" id="FN1"><label>*</label>
<p id="P1">Corresponding author. Department of Medicine, Div. of Infectious Diseases-Center for AIDS Research, Center for Infectious Disease Research in Zambia, University of Alabama at Birmingham, Community Care Building, 908-20th Street South, Birmingham, AL 35294, USA. Fax: +1 205 975 6448. <italic>E-mail address:</italic>
<email>gparham@uabmc.edu</email>
(G.P. Parham).</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>21</day>
<month>7</month>
<year>2009</year>
</pub-date>
<pub-date pub-type="epub"><day>27</day>
<month>7</month>
<year>2006</year>
</pub-date>
<pub-date pub-type="ppub"><month>12</month>
<year>2006</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>22</day>
<month>9</month>
<year>2009</year>
</pub-date>
<volume>103</volume>
<issue>3</issue>
<fpage>1017</fpage>
<lpage>1022</lpage>
<permissions><copyright-statement>© 2006 Elsevier Inc. All rights reserved.</copyright-statement>
<copyright-year>2006</copyright-year>
</permissions>
<abstract><sec id="S1"><title>Objectives</title>
<p id="P2">HIV-infected women living in resource-constrained nations like Zambia are now accessing antiretroviral therapy and thus may live long enough for HPV-induced cervical cancer to manifest and progress. We evaluated the prevalence and predictors of cervical squamous intraepithelial lesions (SIL) among HIV-infected women in Zambia.</p>
</sec>
<sec sec-type="methods" id="S2"><title>Methods</title>
<p id="P3">We screened 150 consecutive, non-pregnant HIV-infected women accessing HIV/AIDS care services in Lusaka, Zambia. We collected cervical specimens for cytological analysis by liquid-based monolayer cytology (ThinPrep Pap Test®) and HPV typing using the Roche Linear Array® PCR assay.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P4">The median age of study participants was 36 years (range 23-49 years) and their median CD4+ count was 165/μL (range 7-942). The prevalence of SIL on cytology was 76% (114/150), of which 23.3% (35/150) women had low-grade SIL, 32.6% (49/150) had high-grade SIL, and 20% (30/150) had lesions suspicious for squamous cell carcinoma (SCC). High-risk HPV types were present in 85.3% (128/150) women. On univariate analyses, age of the participant, CD4+ cell count, and presence of any high-risk HPV type were significantly associated with the presence of severely abnormal cytological lesions (i.e., high-grade SIL and lesions suspicious for SCC). Multivariable logistic regression modeling suggested the presence of any high-risk HPV type as an independent predictor of severely abnormal cytology (adjusted OR: 12.4, 95% CI 2.62-58.1, <italic>p</italic>
=0.02).</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P5">The high prevalence of abnormal squamous cytology in our study is one of the highest reported in any population worldwide. Screening of HIV-infected women in resource-constrained settings like Zambia should be implemented to prevent development of HPV-induced SCC.</p>
</sec>
</abstract>
<kwd-group><kwd>HIV</kwd>
<kwd>Cervical Cancer</kwd>
<kwd>Screening</kwd>
<kwd>Cytology</kwd>
<kwd>Zambia</kwd>
</kwd-group>
<contract-num rid="TW1">D43 TW001035-08</contract-num>
<contract-sponsor id="TW1">Fogarty International Center : FIC</contract-sponsor>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F65 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000F65 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaSubSaharaV1 |flux= Pmc |étape= Corpus |type= RBID |clé= PMC:2748907 |texte= Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:16875716" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a SidaSubSaharaV1
![]() | This area was generated with Dilib version V0.6.32. | ![]() |